Variant report
Variant | esv2563049 |
---|---|
Chromosome Location | chr7:136850762-136852698 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:3)
- CpG islands (count:61)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:3 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr7:136851292-136851308 | H1-hESC | embryonic stem cell: | n/a | n/a |
2 | CEBPB | chr7:136851211-136851370 | K562 | blood: | n/a | chr7:136851307-136851316 |
3 | CEBPB | chr7:136851161-136851454 | IMR90 | lung: | n/a | chr7:136851307-136851316 |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:136850736-136850786 | HCM | heart: | n/a |
2 | chr7:136850736-136850786 | HEK293 | kidney: | embryo |
3 | chr7:136850736-136850786 | HEEpiC | esophagus: | n/a |
4 | chr7:136850736-136850786 | K562 | blood: | n/a |
5 | chr7:136850736-136850786 | SK-N-MC | brain: | n/a |
6 | chr7:136850736-136850786 | GM12891 | blood: | n/a |
7 | chr7:136850736-136850786 | HNPCEpiC | eye: | n/a |
8 | chr7:136850736-136850786 | PrEC | prostate: | n/a |
9 | chr7:136850736-136850786 | LNCaP | prostate: | n/a |
10 | chr7:136850736-136850786 | PFSK-1 | brain: | n/a |
11 | chr7:136850736-136850786 | MCF10A-Er-Src | breast: | n/a |
12 | chr7:136850736-136850786 | GM06990 | blood: | n/a |
13 | chr7:136850736-136850786 | HRPEpiC | eye: | n/a |
14 | chr7:136850736-136850786 | BE2_C | brain: | n/a |
15 | chr7:136850736-136850786 | HCPEpiC | choroid plexus: | n/a |
16 | chr7:136850736-136850786 | BJ | skin: | n/a |
17 | chr7:136850736-136850786 | Caco-2 | colon: | n/a |
18 | chr7:136850736-136850786 | HMEC | breast: | n/a |
19 | chr7:136850736-136850786 | ovcar-3 | ovarian: | n/a |
20 | chr7:136850736-136850786 | NHBE | bronchial: | n/a |
21 | chr7:136850736-136850786 | HRCEpiC | kidney: | n/a |
22 | chr7:136850736-136850786 | U87 | brain: | n/a |
23 | chr7:136850736-136850786 | RPTEC | kidney: | n/a |
24 | chr7:136850736-136850786 | AG04449 | skin: | fetal |
25 | chr7:136850736-136850786 | ProgFib | skin: | n/a |
26 | chr7:136850736-136850786 | IMR90 | lung: | fetal |
27 | chr7:136850736-136850786 | H1-hESC | embryonic stem cell: | embryo |
28 | chr7:136850736-136850786 | HepG2 | liver: | n/a |
29 | chr7:136850736-136850786 | MCF-7 | breast: | n/a |
30 | chr7:136850736-136850786 | AG10803 | skin: | n/a |
31 | chr7:136850736-136850786 | CMK | blood: | n/a |
32 | chr7:136850736-136850786 | AG09319 | gingival: | n/a |
33 | chr7:136850736-136850786 | NT2-D1 | testis: | n/a |
34 | chr7:136850736-136850786 | NB4 | blood: | n/a |
35 | chr7:136850736-136850786 | Hela-S3 | cervix: | n/a |
36 | chr7:136850736-136850786 | HL-60 | blood: | n/a |
37 | chr7:136850736-136850786 | AG09309 | skin: | n/a |
38 | chr7:136850736-136850786 | SKMC | muscle: | n/a |
39 | chr7:136850736-136850786 | HIPEpiC | eye: | n/a |
40 | chr7:136850736-136850786 | A549 | lung: | n/a |
41 | chr7:136850736-136850786 | HUVEC | blood vessel: | n/a |
42 | chr7:136850736-136850786 | Hepatocyte | liver: | n/a |
43 | chr7:136850736-136850786 | HCF | heart: | n/a |
44 | chr7:136850736-136850786 | HRE | kidney: | n/a |
45 | chr7:136850736-136850786 | GM12878 | blood: | n/a |
46 | chr7:136850736-136850786 | NH-A | brain: | n/a |
47 | chr7:136850736-136850786 | T-47D | breast: | n/a |
48 | chr7:136850736-136850786 | SK-N-SH_RA | brain: | n/a |
49 | chr7:136850736-136850786 | SK-N-SH | brain: | n/a |
50 | chr7:136850736-136850786 | SAEC | small airway: | n/a |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000234352 | TF binding region |
ENSG00000234352 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs200861276 | chr7:136850789-136850790 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs200970066 | chr7:136850791-136850792 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs386411441 | chr7:136850792-136850793 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs72574895 | chr7:136850793-136850794 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs397797362 | chr7:136850794-136850795 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs113706539 | chr7:136850899-136850900 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs201052904 | chr7:136850901-136850902 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs201683620 | chr7:136850903-136850904 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs199959492 | chr7:136850904-136850905 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs560690768 | chr7:136850953-136850954 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs35679992 | chr7:136850984-136850985 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs192804438 | chr7:136850986-136850987 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs549125545 | chr7:136851037-136851038 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs33914231 | chr7:136851039-136851040 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs531376473 | chr7:136851065-136851066 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs551097922 | chr7:136851072-136851073 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs78217012 | chr7:136851176-136851177 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs832959 | chr7:136851227-136851228 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs184920829 | chr7:136851229-136851230 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs144684635 | chr7:136851302-136851303 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs554167843 | chr7:136851407-136851408 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs535533645 | chr7:136851415-136851416 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs555876511 | chr7:136851474-136851475 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs832958 | chr7:136851486-136851487 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs547970749 | chr7:136851581-136851582 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs544556061 | chr7:136851626-136851627 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs557872833 | chr7:136851627-136851628 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs367695011 | chr7:136851628-136851629 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs371254146 | chr7:136851706-136851707 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs568084333 | chr7:136851756-136851757 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs533533755 | chr7:136851768-136851769 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs547296463 | chr7:136851770-136851771 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs566792769 | chr7:136851775-136851776 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs560655795 | chr7:136851776-136851777 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs538854520 | chr7:136851902-136851903 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs71176385 | chr7:136851920-136851921 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs67986741 | chr7:136851921-136851922 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs529555923 | chr7:136852131-136852132 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs833013 | chr7:136852147-136852148 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs138557158 | chr7:136852167-136852168 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs531307622 | chr7:136852240-136852241 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs34590530 | chr7:136852313-136852314 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs140117310 | chr7:136852420-136852421 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs117000853 | chr7:136852437-136852438 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs547316111 | chr7:136852456-136852457 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs567120726 | chr7:136852457-136852458 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs536083633 | chr7:136852463-136852464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs117451743 | chr7:136852481-136852482 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs569290119 | chr7:136852539-136852540 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs188138451 | chr7:136852610-136852611 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Melanoma | 19188590 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Coffin-Siris syndrome | 21572526 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Breast cancer | 21509527 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Low-grade fibromyxoid sarcoma | 21536545 | CNVD |
Breast cancer | 16272173 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Stuttering | 21108403 | CNVD |
Breast cancer | 17603634 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Neuroticism | 17667963 | CNVD |
Myelodysplastic syndrome | 17634407 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:136849600-136851200 | Enhancers | Fetal Stomach | stomach |
2 | chr7:136850000-136851200 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
3 | chr7:136850400-136850800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
4 | chr7:136850400-136854000 | Weak transcription | Fetal Kidney | kidney |
5 | chr7:136850600-136851600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
6 | chr7:136850800-136851600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
7 | chr7:136851200-136851400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
8 | chr7:136851200-136853800 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
9 | chr7:136851200-136853800 | Weak transcription | Fetal Stomach | stomach |